Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-31 @ 9:37 AM
Study NCT ID:
NCT02347332
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2014-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer
Sponsor:
Pierre Fabre Medicament
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-18
First Submit QC Date:
None
Study First Post Date:
2015-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-26
Results First Submit QC Date:
None
Results First Post Date:
2019-02-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-13
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL